The Pfizer vaccine does not increase cardiovascular risk in people over 75 years of age
Start COVID-19 vaccine Frequently asked questions Where can I get vaccinated? Check if you can get vaccinated

The Covid-19 vaccine from Pfizer / BioNTech does not increase the risk of serious cardiovascular problems such as heart attacks, strokes and pulmonary embolism in people over the age of 75, according to a French study published on Monday.

The researchers say their work “reassuringly indicates that vaccination with” Pfizer / BioNTech “does not appear to be associated with an increased risk of serious cardiovascular events in people aged 75 and over”, both after the first and second administration. doses.

  1. These heavy NOPs come after Pfizer and Moderna. Also in Poland

The research was carried out as part of the Epi-Phare research group, which associates the French National Medicines Safety Agency (ANSM) and the National Health Insurance Fund (CNAM).

The researchers considered all cases of heart attacks, strokes and pulmonary embolisms hospitalized in France between December 2020 and March 2021 in people aged 75 and older, both vaccinated and unvaccinated. In total, it was a group of almost 30 thousand. people. Researchers compared the prevalence of cardiovascular problems at different times; The 14-day periods after the first and second dose of vaccine were taken as the risk periods and all others as control periods.

‘Overall, the frequency of hospital admissions for myocardial infarction, ischemic stroke, hemorrhagic stroke and pulmonary embolism in people aged 75 and older did not differ significantly’ between these different periods, the study concluded.

Epi-Phare scientists now plan to update this data. “As soon as information is available, analyzes will continue to measure this risk, especially in people with a history of cardiovascular events, in younger populations, and for other Covid-19 vaccines,” it said.

In France, the vaccination campaign began at the end of December 2020 and initially only targeted elderly people, mainly vaccinated with the Pfizer / BioNTech preparation.

In May, in a previous study focused on the Pfizer / BioNTech vaccine, the Epi-Phare group found that the vaccination reduced the risk of developing severe Covid-19 by 87%. in people over 75 years of age, just seven days after the second dose.

Have you been infected with COVID-19 and are worried about the side effects? Check your health by performing a comprehensive test package for convalescents.

Read also:

  1. Virologist: Fourth Wave Mid-August. It will hit eastern Poland
  2. Drama in Indonesia. Gravediggers go around the houses collecting bodies
  3. How long will the J&J vaccine protect? There is new research

The content of the medTvoiLokony website is intended to improve, not replace, the contact between the Website User and their doctor. The website is intended for informational and educational purposes only. Before following the specialist knowledge, in particular medical advice, contained on our Website, you must consult a doctor. The Administrator does not bear any consequences resulting from the use of information contained on the Website. Do you need a medical consultation or an e-prescription? Go to halodoctor.pl, where you will get online help – quickly, safely and without leaving your home.

Leave a Reply